1. Home
  2. LEGN vs EDU Comparison

LEGN vs EDU Comparison

Compare LEGN & EDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • EDU
  • Stock Information
  • Founded
  • LEGN 2014
  • EDU 1993
  • Country
  • LEGN United States
  • EDU China
  • Employees
  • LEGN N/A
  • EDU N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • EDU Other Consumer Services
  • Sector
  • LEGN Health Care
  • EDU Real Estate
  • Exchange
  • LEGN Nasdaq
  • EDU Nasdaq
  • Market Cap
  • LEGN 6.3B
  • EDU 8.5B
  • IPO Year
  • LEGN 2020
  • EDU 2006
  • Fundamental
  • Price
  • LEGN $32.57
  • EDU $58.56
  • Analyst Decision
  • LEGN Strong Buy
  • EDU Buy
  • Analyst Count
  • LEGN 12
  • EDU 6
  • Target Price
  • LEGN $70.82
  • EDU $56.87
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • EDU 1.1M
  • Earning Date
  • LEGN 11-11-2025
  • EDU 10-28-2025
  • Dividend Yield
  • LEGN N/A
  • EDU N/A
  • EPS Growth
  • LEGN N/A
  • EDU 27.50
  • EPS
  • LEGN N/A
  • EDU 2.29
  • Revenue
  • LEGN $796,838,000.00
  • EDU $4,900,262,000.00
  • Revenue This Year
  • LEGN $70.27
  • EDU $9.95
  • Revenue Next Year
  • LEGN $50.28
  • EDU $9.91
  • P/E Ratio
  • LEGN N/A
  • EDU $26.40
  • Revenue Growth
  • LEGN 74.75
  • EDU 13.60
  • 52 Week Low
  • LEGN $27.34
  • EDU $40.66
  • 52 Week High
  • LEGN $47.79
  • EDU $68.53
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 43.02
  • EDU 52.45
  • Support Level
  • LEGN $31.44
  • EDU $55.14
  • Resistance Level
  • LEGN $32.45
  • EDU $61.56
  • Average True Range (ATR)
  • LEGN 1.39
  • EDU 2.01
  • MACD
  • LEGN 0.06
  • EDU 0.14
  • Stochastic Oscillator
  • LEGN 28.29
  • EDU 50.00

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About EDU New Oriental Education & Technology Group Inc.

New Oriental Education & Technology is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation and consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.

Share on Social Networks: